Pediatric Drug Therapy 2021 | Psychotropic Medications for Challenging Behaviors and Co-occurring Psychiatric Disorders in Autism

Pediatric Drug Therapy 2021

Psychotropic Medications for Challenging Behaviors and Co-occurring Psychiatric Disorders in Autism

On-Demand Program

Speaker

David Camenisch, MD, MPH, Clinical Psychiatrist, Seattle Children’s Autism Center; Consultant, Partnership Access Line; Psychiatric and Medical Consultant, Catholic Community Services of Western Washington

Target Audience

For pediatric nurse practitioners, family nurse practitioners, physician assistants, clinical nurse specialists, nurses, respiratory therapists, pharmacists and other interested healthcare professionals.

Objectives for Learning Outcomes

At the conclusion of this activity, participants will be better able to:

1. Learn about the epidemiology of psychotropic medication utilization and co-occurring psychiatric disorders in ASD.
2. Be introduced to guidelines and strategies of pharmacotherapy in children and adolescent with autism.
3. Improve their knowledge of medication strategies for treating challenging behaviors and co-occurring psychiatric disorders in ASD.